Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
Moazzam Ali(World Health Organization), David Hubacher(Family Health International 360), Sihem Landoulsi(World Health Organization), Ndema Habib(World Health Organization), Luís Bahamondes(Universidade Estadual de Campinas (UNICAMP)), Vivian Brache(Profamilia), Ayşe Akın(Başkent University)
Cited by 127
Related Papers
Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis
|The Lancet Global Health|2018|3.1k
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination
|Nature Medicine|2022|418
Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial
|Reproductive Health|2013|161
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men
|The Journal of Clinical Endocrinology & Metabolism|2016|139